Officers

Matt Patterson Headshot
Chairman

Matt Patterson

Strategic Advisor,
Audentes, an Astellas Company
Emile Nuwaysir Headshot
Vice Chairman

Emile Nuwaysir

President and Chief Executive Officer,
BlueRock Therapeutics
Amy Butler Headshot
Secretary

Amy Butler

President, Biosciences,
Thermo Fisher Scientific
Jeffrey Walsh Headshot
Treasurer

Jeffrey Walsh

Former Chief Financial and Strategy Officer,
bluebird bio

Board of Directors

Zami Aberman

Chairman and Co-Chief Executive Officer,
Pluristem Therapeutics

Usman Azam

Chief Executive Officer,
Tmunity Therapeutics

Rita Balice-Gordon

Global Head of Rare and Neurologic Diseases Therapeutic Area,
Sanofi

Ron Bartek

Co-Founder and President,
Friedreich's Ataxia Research Alliance

Amy Butler

President, Biosciences,
Thermo Fisher Scientific

Bradley Campbell

President and Chief Operating Officer,
Amicus Therapeutics

Cindy Collins

President and Chief Executive Officer,
Editas Medicine

Miguel Forte

Chief Executive Officer,
Bone Therapeutics

Kristen Harrington-Smith

VP and Head, CAR-T US,
Novartis Oncology

Michael Hunt

Chief Financial Officer,
ReNeuron

Jerry Kebyl

Head of Cell and Gene Therapy Manufacturing,
MilliporeSigma

Paul Laikind

President and Chief Executive Officer,
ViaCyte

Ann Lee

Senior Vice President and Head of Cell Therapy Development & Operations,
Bristol-Myers Squibb

Bruce Levine

Founding Director, Clinical Cell and Vaccine Production Facility,
Abramson Cancer Center, University of Pennsylvania

John Maslowski

Chief Executive Officer,
Castle Creek Pharmaceuticals

Claudia Mitchell

Senior VP, Product and Portfolio Strategy,
Astellas Pharma

Emile Nuwaysir

President and Chief Executive Officer,
BlueRock Therapeutics

Matt Patterson

Strategic Advisor,
Audentes, an Astellas Company

Isabelle Riviere

Director, Cell Therapy and Cell Engineering Facility,
Memorial Sloan Kettering Cancer Center

Jeff Ross

Chief Executive Officer,
Miromatrix Medical

Mark Rothera

President and Chief Executive Officer,
Orchard Therapeutics

Curran Simpson

Senior Vice President, Product Development, and Chief Technical Officer,
REGENXBIO

Sanjaya Singh

Vice President and Global Head,
Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Research & Development

Bob Smith

Senior Vice President, Global Gene Therapy Business,
Pfizer

Devyn Smith

Chief Operating Officer,
Sigilon Therapeutics

Joe Tarnowski

Senior Vice President, Cell and Gene Therapy Platform,
GlaxoSmithKline

Arthur Tzianabos

President and Chief Executive Officer,
Homology Medicines

Gil Van Bokkelen

President and Chief Executive Officer,
Athersys

Christopher Vann

Chief Operating Officer,
Autolus Therapeutics

Jeffrey Walsh

Former Chief Financial and Strategy Officer,
bluebird bio

Susan Washer

President and Chief Executive Officer,
AGTC

Executive Committee

Usman Azam

Chief Executive Officer,
Tmunity Therapeutics

Amy Butler

President, Biosciences,
Thermo Fisher Scientific

Michael Hunt

Chief Financial Officer,
ReNeuron

Claudia Mitchell

Senior VP, Product and Portfolio Strategy,
Astellas Pharma

Emile Nuwaysir

President and Chief Executive Officer,
BlueRock Therapeutics

Matt Patterson

Strategic Advisor,
Audentes, an Astellas Company

Bob Smith

Senior Vice President, Global Gene Therapy Business,
Pfizer

Devyn Smith

Chief Operating Officer,
Sigilon Therapeutics

Jeffrey Walsh

Former Chief Financial and Strategy Officer,
bluebird bio